Natural Product: NPC544348

Natural Product IDNPC544348
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Gymnestrogenin
IUPAC Name (3~{S},4~{a}~{S},5~{S},6~{a}~{R},6~{a}~{S},6~{b}~{R},8~{a}~{R},9~{R},10~{S},12~{a}~{R},14~{b}~{S})-4~{a},9-bis(hydroxymethyl)-2,2,6~{a},6~{b},9,12~{a}-hexamethyl-1,3,4,5,6,6~{a},7,8,8~{a},10,11,12,13,14~{b}-tetradecahydropicene-3,5,10-triol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SIBYGGBNBRCVQI-DGNDGBPUSA-N
Standard InCHI InChI=1S/C30H50O5/c1-25(2)13-19-18-7-8-21-26(3)11-10-22(33)27(4,16-31)20(26)9-12-28(21,5)29(18,6)14-24(35)30(19,17-32)15-23(25)34/h7,19-24,31-35H,8-17H2,1-6H3/t19-,20+,21+,22-,23-,24-,26-,27-,28+,29+,30+/m0/s1
SMILES CC1(C)C[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(CO)C[C@@H]1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   490.37 Volume:   525.968
?
Van der Waals volume.
Dense:   0.932 LogP:   2.923
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.112
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.461
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   26.0
TPSA:   101.15
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   5.0 Rings:   5.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.376 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.237 Fsp3:   0.933
MCE-18:   107.586
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.422 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.008
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.391 Promiscuous compounds:   0.133

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.091 MDCK Permeability:   -4.75
Pgp-inhibitor:   0.004 Pgp-substrate:   0.392
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.027
20% Bioavailability (F20%):   0.986 30% Bioavailability (F30%):   0.148
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.893 MRP1:   0.145
Plasma Protein Binding (PPB):   82.226% Volume Distribution (VD):   -0.142
Fu: 16.813%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.998
OATP1B3 inhibitor:   0.025 BCRP inhibitor:   0.97
BSEP inhibitor:   0.71

ADMET: Metabolism

CYP1A2-inhibitor:   0.008 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.975 CYP2C19-substrate:   0.772
CYP2C9-inhibitor:   0.002 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.011 CYP3A4-substrate:   0.079
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.751
HLM stability:   0.08
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.568 Half-life (T1/2):  1.049

ADMET: Toxicity

hERG Blockers:  0.019 hERG Blockers (10um):  0.078
Human Hepatotoxicity (H-HT):  0.586 Drug-induced Liver Injury (DILI):  0.139
AMES Toxicity:  0.689 Rat Oral Acute Toxicity:  0.688
Maximum Recommended Daily Dose:  0.594 Skin Sensitization:  0.985
Carcinogencity:  0.943 Eye Corrosion:  0.0
Eye Irritation:  0.258 Respiratory Toxicity:  0.817
Drug-induced Neurotoxicity:  0.053 Ototoxicity:  0.729
Hematotoxicity:  0.6 Drug-induced Nephrotoxicity:  0.705
Genotoxicity:  0.405 RPMI-8226 Immunitoxicity:  0.074
A549 Cytotoxicity:  0.96 Hek293 Cytotoxicity:  0.53
BCF:   1.171
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.544
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.139
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.262
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29166 Gymnema sylvestre Species Apocynaceae Eukaryota n.a. n.a. n.a. DOI[10.1007/s11274-011-0870-8]
NPO29166 Gymnema sylvestre Species Apocynaceae Eukaryota n.a. n.a. n.a. DOI[10.1007/s11627-014-9655-8]
NPO29166 Gymnema sylvestre Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO29166 Gymnema sylvestre Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO29166 Gymnema sylvestre Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO29166 Gymnema sylvestre Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO29166 Gymnema sylvestre Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC544348 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7586 Intermediate Similarity NPC253402
0.6833 Remote Similarity NPC253807
0.6833 Remote Similarity NPC158662
0.6452 Remote Similarity NPC230295
0.6452 Remote Similarity NPC159168
0.6452 Remote Similarity NPC98386
0.6393 Remote Similarity NPC196753
0.6129 Remote Similarity NPC311078
0.6061 Remote Similarity NPC213412
0.5972 Remote Similarity NPC258547
0.5735 Remote Similarity NPC229281
0.5714 Remote Similarity NPC263393
0.5692 Remote Similarity NPC53744
0.5625 Remote Similarity NPC34177
0.5507 Remote Similarity NPC270768
0.5507 Remote Similarity NPC59263
0.5507 Remote Similarity NPC210106
0.5507 Remote Similarity NPC121798
0.5507 Remote Similarity NPC234346
0.5493 Remote Similarity NPC191412
0.5493 Remote Similarity NPC114159
0.5493 Remote Similarity NPC6818
0.5429 Remote Similarity NPC61543
0.5429 Remote Similarity NPC293048
0.5429 Remote Similarity NPC225585
0.5385 Remote Similarity NPC101475
0.5342 Remote Similarity NPC116457
0.5303 Remote Similarity NPC235341
0.5286 Remote Similarity NPC488519
0.5205 Remote Similarity NPC127689
0.5205 Remote Similarity NPC130520
0.52 Remote Similarity NPC86368
0.52 Remote Similarity NPC283343
0.5156 Remote Similarity NPC290598
0.5156 Remote Similarity NPC30590
0.5152 Remote Similarity NPC237344
0.5147 Remote Similarity NPC133954
0.5139 Remote Similarity NPC164349
0.5132 Remote Similarity NPC473160
0.5125 Remote Similarity NPC237503
0.5075 Remote Similarity NPC480924

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC544348 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.597 Remote Similarity NPD7645 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data